This company has been marked as potentially delisted and may not be actively trading. Histogenics (HSGX) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock HSGX vs. APT, MLSS, LGMK, SIBN, ARVN, PHLT, CLPT, ERAS, SVRA, and KALVShould you be buying Histogenics stock or one of its competitors? The main competitors of Histogenics include Alpha Pro Tech (APT), Milestone Scientific (MLSS), LogicMark (LGMK), SiBone (SIBN), Arvinas (ARVN), Performant Healthcare (PHLT), ClearPoint Neuro (CLPT), Erasca (ERAS), Savara (SVRA), and KalVista Pharmaceuticals (KALV). Histogenics vs. Its Competitors Alpha Pro Tech Milestone Scientific LogicMark SiBone Arvinas Performant Healthcare ClearPoint Neuro Erasca Savara KalVista Pharmaceuticals Histogenics (NASDAQ:HSGX) and Alpha Pro Tech (NYSE:APT) are both small-cap surgical appliances & supplies industry companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, media sentiment, risk, valuation, dividends, profitability and analyst recommendations. Do insiders & institutionals hold more shares of HSGX or APT? 40.4% of Histogenics shares are owned by institutional investors. Comparatively, 22.7% of Alpha Pro Tech shares are owned by institutional investors. 19.7% of Histogenics shares are owned by company insiders. Comparatively, 15.0% of Alpha Pro Tech shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has better earnings and valuation, HSGX or APT? Alpha Pro Tech has higher revenue and earnings than Histogenics. Histogenics is trading at a lower price-to-earnings ratio than Alpha Pro Tech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHistogenicsN/AN/A-$8.64M-$0.79-2.32Alpha Pro Tech$58.56M0.84$4.19M$0.3413.82 Which has more volatility and risk, HSGX or APT? Histogenics has a beta of 3.1, indicating that its share price is 210% more volatile than the S&P 500. Comparatively, Alpha Pro Tech has a beta of 0.45, indicating that its share price is 55% less volatile than the S&P 500. Is HSGX or APT more profitable? Alpha Pro Tech has a net margin of 6.99% compared to Histogenics' net margin of 0.00%. Alpha Pro Tech's return on equity of 6.70% beat Histogenics' return on equity.Company Net Margins Return on Equity Return on Assets HistogenicsN/A -34.96% 18.40% Alpha Pro Tech 6.99%6.70%5.76% Does the media favor HSGX or APT? In the previous week, Alpha Pro Tech had 1 more articles in the media than Histogenics. MarketBeat recorded 1 mentions for Alpha Pro Tech and 0 mentions for Histogenics. Alpha Pro Tech's average media sentiment score of 1.95 beat Histogenics' score of 0.00 indicating that Alpha Pro Tech is being referred to more favorably in the news media. Company Overall Sentiment Histogenics Neutral Alpha Pro Tech Very Positive SummaryAlpha Pro Tech beats Histogenics on 8 of the 12 factors compared between the two stocks. Get Histogenics News Delivered to You Automatically Sign up to receive the latest news and ratings for HSGX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HSGX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HSGX vs. The Competition Export to ExcelMetricHistogenicsSurgical Appliances & Supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$173.12M$24.68M$6.11B$10.63BDividend YieldN/AN/A5.66%4.71%P/E Ratio-2.3212.7085.2726.57Price / SalesN/A1.84612.79132.63Price / CashN/A12.8038.5062.09Price / Book-183.001.8712.726.53Net Income-$8.64M-$5.31M$3.30B$275.96M Histogenics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HSGXHistogenicsN/A$1.83+2.2%N/A+86.8%$173.12MN/A-2.3249APTAlpha Pro Tech2.8396 of 5 stars$4.80+0.3%N/A-16.6%$50.22M$58.56M12.96120Positive NewsMLSSMilestone Scientific2.445 of 5 stars$0.45-0.9%$1.25+177.5%-37.2%$35.38M$9.08M-6.4330News CoverageGap UpLGMKLogicMark0.156 of 5 stars$0.00flatN/A-99.9%$1.84M$9.88M0.0020Gap DownSIBNSiBone3.888 of 5 stars$14.27-3.1%$23.67+65.8%+22.4%$635.03M$167.18M-25.48350Positive NewsAnalyst ForecastARVNArvinas3.0727 of 5 stars$9.13+7.2%$16.18+77.3%-61.6%$625.52M$263.40M-9.04420Analyst ForecastPHLTPerformant Healthcare1.1594 of 5 stars$7.71-0.3%$7.88+2.1%N/A$621.80M$122.98M-771.00930News CoverageAnalyst ForecastCLPTClearPoint Neuro0.5896 of 5 stars$20.91-4.0%$19.67-5.9%+138.7%$619.43M$31.39M-25.81110Analyst ForecastERASErasca2.5018 of 5 stars$2.21+1.4%$3.71+68.1%-5.8%$618.40MN/A-4.91120News CoverageAnalyst ForecastOptions VolumeSVRASavara2.7499 of 5 stars$3.54-0.8%$7.50+111.9%-6.3%$617.03MN/A-7.0820Trending NewsAnalyst ForecastKALVKalVista Pharmaceuticals3.7394 of 5 stars$12.05-1.1%$26.43+119.3%+5.1%$615.37MN/A-3.06100Analyst Forecast Related Companies and Tools Related Companies APT Competitors MLSS Competitors LGMK Competitors SIBN Competitors ARVN Competitors PHLT Competitors CLPT Competitors ERAS Competitors SVRA Competitors KALV Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HSGX) was last updated on 10/10/2025 by MarketBeat.com Staff From Our Partners$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredWhat the hell is going on, America?America’s $37.5 trillion debt spiral, soaring deficits, and repeated credit downgrades are exactly what Porter...Porter & Company | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredGOLD ALERTGold has shattered records, soaring past $3,800 an ounce... But Stansberry Senior Partner Dr. David "Doc" E...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTexit: The $1.4 trillion reason why tech is fleeing Cali for TexasThe state of Texas recently made a critical change to its laws… In a quest to become the AI data center cap...Brownstone Research | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Histogenics Corp Please log in to your account or sign up in order to add this asset to your watchlist. Share Histogenics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
